22 Jan 2009 11:58
| TR-1: Notifications of Major Interests in Shares |
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | Immunodiagnostic Systems Holdings plc | ||
| 2. Reason for notification (yes/no) | |||
| An acquisition or disposal of voting rights | |||
| An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||
| An event changing the breakdown of voting rights | |||
| Other (please specify): This notification corrects for an earlier announcement, released on 10 December 2008, regarding Forum's holding in the Company. Following the issue of equity by the Company, as announced on 10 December 2008, Forum actually held 4,221,064 shares in the Company which represents 15.98% of the Company's issued share capital, and not 4,221,064 shares (16.52%) as stated in the announcement. All other information in that announcement relating to Forum remains correct. | Yes | ||
| 3. Full name of person(s) subject to notification obligation: | Forum Venture Capital GmbH | ||
| 4. Full name of shareholder(s) (if different from 3): | |||
| 5. Date of transaction (and date on which the threshold is crossed or reached if different): | n/a | ||
| 6. Date on which issuer notified: | 20 January 2009 | ||
| 7. Threshold(s) that is/are crossed or reached: | n/a | ||
| 8. Notified details: | |||
| A: Voting rights attached to shares | ||||||||
| Class/type of shares If possible use ISIN code | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | ||||||
| Number of shares | Number of voting rights | Number of shares | Number of voting rights | Percentage of voting rights | ||||
| Direct | Indirect | Direct | Indirect | |||||
| GB00B01YZ052 | 3,719,526 | 3,719,526 | 4,221,064 |
4,221,064 | 15.98% | |||
| B: Financial Instruments | ||||
| Resulting situation after the triggering transaction | ||||
| Type of financial instrument | Expiration date | Exercise/ conversion period/date | No. of voting rights that may be acquired (if the instrument exercised/converted) | Percentage of voting rights |
| Total (A+B) | |
| Number of voting rights | Percentage of voting rights |
| 9. Chain of controlled undertakings through which the voting rights and / or the financial instruments are effectively held; if applicable xv: |
| N/A |
| Proxy Voting: | |
| 10. Name of proxy holder: | N/A |
| 11. Number of voting rights proxy holder will cease to hold: | N/A |
| 12. Date on which proxy holder will cease to hold voting rights: | N/A |
| 13. Additional information: | |
| 14 Contact name: | Burkhard Wittek |
| 15. Contact telephone name: | +49 (0) 89 27 37 49-0 |